Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer

Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer

Mycobacterium bovis bacillus Calmette–Guerin (BCG) remains at the forefront of immunotherapy for treating bladder cancer patients. However, the incidence of recurrence and progression to invasive cancer is commonly observed. There are no established effective intravesical therapies available for pat...

Full description

Bibliographic Details
Main Authors: Julieti Huch Buss, Karine Rech Begnini, Camila Bonemann Bender, Adriana R. Pohlmann, Silvia S. Guterres, Tiago Collares, Fabiana Kömmling Seixas
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-01-01
Series:Frontiers in Pharmacology
Subjects:
bladder cancer
nanotechnology
BCG
Nano-BCG
monoclonal antibody
EGFR
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00977/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00977/full

Similar Items